查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1611288

稀有生物標記檢體採集和穩定市場：按產品類型、採集類型、應用和最終用途 - 2025-2030 年全球預測

Rare Biomarkers Specimen Collection & Stabilization Market by Product Type, Collection Type, Application, End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

稀有生物標記檢體收集和穩定市場2023年估值為299.4億美元，預計到2024年將達到322.1億美元，複合年成長率為7.54%，到2030年預計將達到498.3億美元。

稀有生物標記檢體採集和穩定市場涵蓋專門的醫療保健領域，專注於收集、保存和分析極少量的獨特生物標記。這些生物標記對於早期疾病診斷、個人化醫療和長期健康監測至關重要。這項市場需求源自於對精準醫療日益成長的需求，這需要能夠維持從源頭到分析的生物完整性的敏感技術。應用範圍涵蓋腫瘤學、產前檢測、神經病學和感染疾病診斷，最終用戶包括臨床實驗室、研究和學術機構以及生物製藥公司。診斷技術的進步、生物標記研究資金的增加以及慢性病盛行率的上升推動了市場成長。例如，政府支持個人化醫療的舉措將顯著提升市場潛力。市場擴張機會包括開發自動化和數位解決方案，以簡化檢體採集和穩定工作流程。然而，挑戰依然存在，包括嚴格的法律規範、高昂的營運成本以及管理檢體隨時間劣化的技術限制。另一個限制因素是缺乏熟悉尖端生物標記技術的熟練專業人員。創新技術包括開發攜帶式、易於使用的收集設備和新的穩定方法，這些方法可以延長檢體的保存期限，而無需嚴重依賴低溫運輸物流。市場本質上是競爭激烈且分散的，既有老字型大小企業，也有新興企業。技術進步和監管環境的動態本質既帶來了機遇，也帶來了威脅。投資於合作努力，例如與學術研究機構合作進行早期創新，是獲得優勢的一項有前景的策略。公司應專注於適應性技術，進行嚴格的市場情報以預測市場狀況的變化，定位自己以回應新的需求，並利用已發現的差距。

主要市場統計
基準年[2023] 299.4億美元
預計年份 [2024] 322.1億美元
預測年份 [2030] 498.3億美元
複合年成長率（%） 7.54%

市場動態：針對快速發展的稀有生物標記檢體採集和穩定市場揭示的關鍵市場見解

供需的動態交互作用正在改變稀有生物標記檢體採集和穩定市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 人們越來越偏好非侵入性疾病治療
    • 個人化醫療需求不斷成長
    • 越來越多的研究闡明循環生物標記的作用
  • 市場限制因素
    • 行業監管嚴格
  • 市場機會
    • 液態切片活體組織切片等新檢測方法的創新
    • 聯合市場開拓舉措
  • 市場挑戰
    • 有限兌換場景
    • 表徵複雜性和低效的分離通訊協定

波特的五力：駕馭稀有生物標記檢體採集和穩定市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解稀有生物標記檢體採集和穩定市場的外部影響

外部宏觀環境因素在塑造稀有生物標記檢體收集和穩定市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解稀有生物標記檢體採集和穩定市場的競爭狀況

稀有生物標記物檢體採集和穩定市場的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣評估供應商在稀有生物標記檢體收集和穩定市場的表現

FPNV 定位矩陣是評估稀有生物標記檢體收集和穩定市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製稀有生物標記檢體採集和穩定市場的成功之路

對於希望加強其在全球市場的影響力的公司來說，稀有生物標記檢體採集和穩定市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 非侵入性疾病治療越來越受歡迎
      • 對個人化醫療的需求不斷成長
      • 越來越多的研究描述了循環生物標記的作用
    • 抑制因素
      • 嚴格的行業法規
    • 機會
      • 新的檢測創新，例如液態生物檢體檢測
      • 市場開發聯合舉措
    • 任務
      • 有限兌換場景
      • 表徵複雜性和低效的分離通訊協定
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章稀有生物標記檢體採集與穩定市場：依產品類型

  • 循環細胞遊離DNA
  • 循環性腫瘤細胞
  • 胞外體或細胞外囊泡

第7章稀有生物標記檢體採集與穩定市場（依採集類型）

  • 採血管及採血管系統
  • 分離試劑套件和試劑

第8章稀有生物標記檢體採集與穩定市場：依應用分類

  • 心血管疾病
  • NIPT
  • 腫瘤學
  • 藥物基因組學
  • 人群篩檢
  • 轉錄組學
  • 移植排斥反應

第9章稀有生物標記檢體採集與穩定市場：依最終用途分類

  • 醫院
  • 周產期門診
  • 醫生實驗室
  • 私人或商業實驗室
  • 公共衛生研究所
  • 調查機構

第10章美洲稀有生物標記檢體採集與穩定市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區稀有生物標記檢體採集及穩定市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的稀有生物標記檢體採集和穩定市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • ABL, Inc.
  • ACM Global Laboratories
  • Almac Group
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioAgilytix Labs, LLC
  • bioMerieux, Inc.
  • Charles River Laboratories International, Inc.
  • IQVIA Inc.
  • Labcorp Drug Development
  • NorthEast BioAnalytical Laboratories LLC
  • PerkinElmer Inc.
  • SGS Societe Generale de Surveillance SA
  • Svar Life Science AB
  • Synexa Life Sciences BV
Product Code: MRR-B812DD579A1C

The Rare Biomarkers Specimen Collection & Stabilization Market was valued at USD 29.94 billion in 2023, expected to reach USD 32.21 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 49.83 billion by 2030.

The rare biomarkers specimen collection and stabilization market encompasses a specialized healthcare sector focused on collecting, preserving, and analyzing distinct biological markers that are present in minuscule quantities. These biomarkers are critical for early disease diagnosis, personalized medicine, and longitudinal health monitoring. The necessity of this market arises from the increasing demand for precision medicine, necessitating highly sensitive technologies capable of preserving biological integrity from source to analysis. Applications span oncology, prenatal testing, neurology, and infectious disease diagnostics, with end-users including clinical laboratories, research and academic institutions, and biopharmaceutical companies. Market growth is driven by advances in diagnostic technologies, increased funding for biomarker research, and the rising prevalence of chronic diseases. For instance, government initiatives supporting personalized medicine boost market potential significantly. Opportunities for expansion include developing automation and digital solutions that streamline specimen collection and stabilization workflows. However, challenges persist, including stringent regulatory frameworks, high operational costs, and technological limitations in managing specimen degradation over time. Another limiting factor is the shortage of skilled professionals adept in cutting-edge biomarker technologies. Innovations could include developing portable and user-friendly collection devices and novel stabilization methods that extend the shelf-life of specimens without heavy reliance on cold-chain logistics. The market is inherently competitive and fragmented, characterized by the presence of well-established companies and startups alike. The dynamic nature of technological advancements and regulatory landscapes can be both an opportunity and a threat. Investing in collaborative endeavors, such as partnerships with academic and research institutions for early-stage innovations, presents a promising strategy to stay ahead. Businesses are advised to focus on adaptive technologies and conduct rigorous market intelligence to anticipate shifts in the market landscape, ensuring they are poised to address emerging needs and capitalizing on identified gaps.

KEY MARKET STATISTICS
Base Year [2023] USD 29.94 billion
Estimated Year [2024] USD 32.21 billion
Forecast Year [2030] USD 49.83 billion
CAGR (%) 7.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Rare Biomarkers Specimen Collection & Stabilization Market

The Rare Biomarkers Specimen Collection & Stabilization Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising preference of a non-invasive mode of disease treatment
    • Increasing demand for personalized medicine
    • Growth in number of research studies to depict the role of circulating biomarkers
  • Market Restraints
    • Stringent regulations in the industry
  • Market Opportunities
    • Innovation of novel assays such as liquid biopsy assays
    • Collaborative initiatives for market developments
  • Market Challenges
    • Limited reimbursement scenario
    • Complexities in characterization and ineffective separation protocols

Porter's Five Forces: A Strategic Tool for Navigating the Rare Biomarkers Specimen Collection & Stabilization Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Rare Biomarkers Specimen Collection & Stabilization Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Rare Biomarkers Specimen Collection & Stabilization Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Rare Biomarkers Specimen Collection & Stabilization Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Rare Biomarkers Specimen Collection & Stabilization Market

A detailed market share analysis in the Rare Biomarkers Specimen Collection & Stabilization Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Rare Biomarkers Specimen Collection & Stabilization Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Rare Biomarkers Specimen Collection & Stabilization Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Rare Biomarkers Specimen Collection & Stabilization Market

A strategic analysis of the Rare Biomarkers Specimen Collection & Stabilization Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Rare Biomarkers Specimen Collection & Stabilization Market, highlighting leading vendors and their innovative profiles. These include ABL, Inc., ACM Global Laboratories, Almac Group, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioAgilytix Labs, LLC, bioMerieux, Inc., Charles River Laboratories International, Inc., IQVIA Inc., Labcorp Drug Development, NorthEast BioAnalytical Laboratories LLC, PerkinElmer Inc., SGS Societe Generale de Surveillance SA, Svar Life Science AB, and Synexa Life Sciences BV.

Market Segmentation & Coverage

This research report categorizes the Rare Biomarkers Specimen Collection & Stabilization Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Circulating Cell Free DNA, Circulating Tumor Cells, and Exosomes or Extracellular Vesicles.
  • Based on Collection Type, market is studied across Blood Collection Tubes & Systems and Isolation Kits & Reagents.
  • Based on Application, market is studied across Cardiovascular Diseases, NIPT, Oncology, Pharmacogenomics, Population Screening, Transcriptomics, and Transplant Rejection.
  • Based on End Use, market is studied across Hospitals, Perinatal Clinics, Physician Labs, Private or Commercial Labs, Public Health Labs, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising preference of a non-invasive mode of disease treatment
      • 5.1.1.2. Increasing demand for personalized medicine
      • 5.1.1.3. Growth in number of research studies to depict the role of circulating biomarkers
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulations in the industry
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovation of novel assays such as liquid biopsy assays
      • 5.1.3.2. Collaborative initiatives for market developments
    • 5.1.4. Challenges
      • 5.1.4.1. Limited reimbursement scenario
      • 5.1.4.2. Complexities in characterization and ineffective separation protocols
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Rare Biomarkers Specimen Collection & Stabilization Market, by Product Type

  • 6.1. Introduction
  • 6.2. Circulating Cell Free DNA
  • 6.3. Circulating Tumor Cells
  • 6.4. Exosomes or Extracellular Vesicles

7. Rare Biomarkers Specimen Collection & Stabilization Market, by Collection Type

  • 7.1. Introduction
  • 7.2. Blood Collection Tubes & Systems
  • 7.3. Isolation Kits & Reagents

8. Rare Biomarkers Specimen Collection & Stabilization Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Diseases
  • 8.3. NIPT
  • 8.4. Oncology
  • 8.5. Pharmacogenomics
  • 8.6. Population Screening
  • 8.7. Transcriptomics
  • 8.8. Transplant Rejection

9. Rare Biomarkers Specimen Collection & Stabilization Market, by End Use

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Perinatal Clinics
  • 9.4. Physician Labs
  • 9.5. Private or Commercial Labs
  • 9.6. Public Health Labs
  • 9.7. Research Institutes

10. Americas Rare Biomarkers Specimen Collection & Stabilization Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Rare Biomarkers Specimen Collection & Stabilization Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Rare Biomarkers Specimen Collection & Stabilization Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ABL, Inc.
  • 2. ACM Global Laboratories
  • 3. Almac Group
  • 4. Becton, Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. BioAgilytix Labs, LLC
  • 7. bioMerieux, Inc.
  • 8. Charles River Laboratories International, Inc.
  • 9. IQVIA Inc.
  • 10. Labcorp Drug Development
  • 11. NorthEast BioAnalytical Laboratories LLC
  • 12. PerkinElmer Inc.
  • 13. SGS Societe Generale de Surveillance SA
  • 14. Svar Life Science AB
  • 15. Synexa Life Sciences BV

LIST OF FIGURES

  • FIGURE 1. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET RESEARCH PROCESS
  • FIGURE 2. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET DYNAMICS
  • TABLE 7. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CIRCULATING CELL FREE DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY EXOSOMES OR EXTRACELLULAR VESICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY BLOOD COLLECTION TUBES & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY ISOLATION KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY NIPT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY POPULATION SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TRANSPLANT REJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PERINATAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PHYSICIAN LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRIVATE OR COMMERCIAL LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PUBLIC HEALTH LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 197. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 198. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, FPNV POSITIONING MATRIX, 2023